Advanced search
Publication Cover
Current Medical Research and Opinion Volume 39, 2023 - Issue 12: Real-World Evidence and Medical Affairs
Submit an article Journal homepage
548
Views
3
CrossRef citations to date
0
Altmetric
Real-World Evidence and Medical Affairs

Time to treatment discontinuation in first-line non-small cell lung carcinoma: an overview

Ruggero Lasalaa Hospital Pharmacy of Corato, Local Health Unit of Bari, ItalyCorrespondence[email protected]
,
Andrea Zovib Ministry of Health, Ministero della Salute, Rome, Italy
,
Valentina Isgròc Clinical Pharmacy, Mediterranean Institute for Transplantation and Advanced Specialized Therapies (ISMETT), Palermo, Italy
,
Alessia Romagnolid Territorial Pharmaceutical Service, Local Health Unit of Lanciano Vasto Chieti, Chieti, Italy
,
Felice Musiccoe Hospital Pharmacy, IRCCS Regina Elena National Cancer Institute, Rome, Italy
&
Fiorenzo Santolerif Hospital Pharmacy, Pescara Hospital, Pescara, Italy
Pages 1603-1612 | Received 18 Jan 2023, Accepted 14 Mar 2023, Published online: 24 Mar 2023

Citations (3)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Ravi Jandhyala. (2023) Guest editor foreword: real-world evidence and medical affairs. Current Medical Research and Opinion 39:12, pages 1537-1539.
Read now

Articles from other publishers (2)

Felice Musicco, Chiara Fulgenzio, Antonia La Malfa, Nicoletta Jannitti, Antonietta Vitiello, Silvia Carpano, Francesca Fusco, Federico Cappuzzo, Irene Terrenato, Isabella Sperduti, Piera Polidori, Domenico Tarantino, Lidia Di Cerbo, Marcello Pani, Valentina Isgrò & Ruggero Lasala. (2024) A real-world multicentre evaluation of atezolizumab plus platinum-etoposide chemotherapy as first-line treatment in patients with extensive-stage small cell lung cancer in Italy. Journal of Oncology Pharmacy Practice.
Crossref
Youssra Salhi, Ronald De Wit & Debbie Robbrecht. (2023) Immunotherapy in Urothelial Cancer: Stop When Achieving a Response, Restart upon Disease Progression. Cancers 15:14, pages 3654.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.